The development of state-of-the-art
blood-contacting devices can
be advanced through integrating hemocompatibility, durability, and
anticoagulant functionalities within engineered nanoscale coatings.
To enable all-aqueous assembly of nanocoatings combining omniphobic
fluorinated features with the potent anticoagulant activity of hydrophilic
heparin, two fluoropolymers containing cationic functionalities were
synthesizedpoly[(trifluoroethoxy)(dimethylaminopropyloxy)phosphazene],
PFAP-O, and poly[(trifluoroethoxy)(dimethylaminopropylamino)phosphazene],
PFAP-A. Despite a relatively high content of fluorinated pendant groupsapproximately
50% (mol) in eachboth polymers displayed solubility in aqueous
solutions and were able to spontaneously form stable supramolecular
complexes with heparin, as determined by dynamic light scattering
and asymmetric flow field-flow fractionation methods. Heparin-containing
coatings were then assembled by layer-by-layer deposition in aqueous
solutions. Nanoassembled coatings were evaluated for potential thrombogenicity
in three important categories of in vitro testscoagulation
by thrombin generation, platelet retention, and hemolysis. In all
assays, heparin-containing fluoro-coatings consistently displayed
superior performance compared to untreated titanium surfaces or fluoro-coatings
assembled using poly(acrylic acid) in the absence of heparin. Short-term
stability studies revealed the noneluting nature of these noncovalently
assembled coatings.